Congenital disorders of glycosylation;Etude des anomalies congénitales de la glycosylation

Annales Pharmaceutiques Francaises

Volumn 61, Issue 5, 2003, Pages 330-339

  Durand, G ^a   Dupre Th ^b   Vuillaumier Barrot, S ^b   Seta, N ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

CDG; Glycosylation; Phosphomannomutase; Phosphomannose isomerase

Indexed keywords

ASPARAGINE; DOLICHOL PHOSPHATE; GLYCAN; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSYLTRANSFERASE; MONOSACCHARIDE; NUCLEOTIDE; TRANSFERRIN;

AUTOSOMAL RECESSIVE DISORDER; BIOSYNTHESIS; CARBOHYDRATE TRANSPORT; CLINICAL FEATURE; CONGENITAL DISORDERS OF GLYCOSYLATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE MUTATION; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; ISOELECTRIC FOCUSING; REVIEW; TRANSFERRIN BLOOD LEVEL; WESTERN BLOTTING;

CARBOHYDRATE METABOLISM, INBORN ERRORS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MUTATION;

EID: 0141480000     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG deficiency, increased serum arylsulphatase A and increase CSF protein: a new syndrom? Pediatr Res 1980; 14: 179.
2. Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 1995; 377: 318-20.
3. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54: 631-64.
4. Schachter H, Glycosyltransferases involved in the synthesis of N-glycann antenae, in Glycoproteins, Elsevier Amsterdam: H. Schachter, Editor; 1995: pp. 153-200.
5. Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate - deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J 1999; 16: 669-71.
6. Burda P, Aebi M. The dolichol pathway of N-linked glycosylation. Biochim Biophys Acta 1999; 1426: 239-57.
7. Abeijon C, Hirschberg CB. Topography of glycosylation reactions in the endoplasmic reticulum. Trends Biochem Sci 1992; 17: 32-6.
8. Hart GW. Glycosylation. Curr Opin Cell Biol 1992; 4: 1017-23.
9. Helenius A. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol Biol Cell 1994; 5: 253-65.
10. Hammond C, Helenius A. Quality control in the secretory pathway. Curr Opin Cell Biol 1995; 7: 523-9.
11. Durand G, Seta N. Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem 2000; 46: 795-805.
12. Biou D, Chanton P, Konan D, Seta N, N'Guyen H, Feger J, et al. Microheterogeneity of the carbohydrate moiety of human alpha 1-acid glycoprotein in two benign liver diseases: alcoholic cirrhosis and acute hepatitis. Clin Chim Acta 1989; 186: 59-66.
13. Serbource-Goguel N, Corbic M, Erlinger S, Durand G, Agneray J, Feger J. Measurement of serum alpha 1-acid glycoprotein and alpha 1-antitrypsin desialylation in liver disease. Hepatology 1983; 3: 356-9.
14. Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, et al. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat 2000; 16: 386-94.
15. de Lonlay P, Seta N, Barrot S, Chabrol B, Drouin V, Gabriel B M, et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 2001; 38: 14-9.
16. Kjaergaard S, Kristiansson B, Stibler H, Freeze HH, Schwartz M, Martinsson T, et al. Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A. Acta Paediatr 1998; 87: 884-8.
17. Niehues R, Hasilik M, Alton G, Korner C, Schiebe-Sukumar M, Koch H G, et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998; 101: 1414-20.
18. de Lonlay P, Cuer M, Vuillaumier-Barrot S, Beaune G, Castelnau P, Kretz M, et al. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr 1999; 135: 379-83.
19. de Koning TJ, Dorland L, van Diggelen OP, Boonman AM, de Jong GJ, van Noort WL, et al. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun 1998; 245: 38-42.
20. Jaeken J, Matthijs G, Saudubray JM, Dionisi-Vici C, Bertini E, de Lonlay P, et al. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 1998; 62: 1535-9.
21. Burda P, Borsig L, de Rijk-van Andel J, Wevers R, Jaeken J, Carchon H, et al. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest 1998; 102: 647-52.
22. Korner C, Knauer R, Holzbach U, Hanefeld F, Lehle L, von Figura K. Carbohydrate-deficient glycoprotein syndrome type V: Deficiency of dolichyl-P-Glc: Man9GlcNAc2-PP-dolichyl glucosyltransferase. Proc Natl Acad Sci USA 1998; 95: 13200-5.
23. Korner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man: Man (5) GlcNAc (2)-PP-dolichyl mannosyltransferase. Embo J 1999; 18: 6816-22.
24. Imbach T, Schenk B, Schollen E, Burda P, Stutz A, Grunewald S, et al. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest 2000; 105: 233-9.
25. Schenk B, Imbach T, Frank CG, Grubenmann C E, Raymond G V, Hurvitz H, et al. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 2001; 108: 1687-95.
26. Chantret I, Dupre T, Delenda C, Bucher S, Dancourt J, Barnier A, et al. Congenital Disorders of Glycosylation (CDG) type Ig is defined by a deficiency in dolichol-P-mannose: Man7GlcNAc2-PP-dolichol mannosyltransferase. J Biol Chem 2002; 277: 25815-22.
27. Chantret I, Dupre T, Dancourt J, Vuillaumier-Barrot S, Ogier de Baulny H, Pelatan C, et al. A deficiency in dolichyl-P-glucose: Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new type of congenital disorders od glycosylation (CDG). J Biol Chem 2002; en ligne.
28. Ramaekers VT, Stibler H, Kint J, Jaeken J. A new variant of the carbohydrate deficient glycoproteins syndrome. J Inherit Metab Dis 1991; 14: 385-8.
29. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994; 71: 123-7.
30. De Praeter CM, Gerwig GJ, Bause E, Nuytinck LK, Vliegenthart J F, Breuer W, et al. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase 1 deficiency. Am J Hum Genet 2000; 66: 1744-56.
31. Marquardt T, Luhn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 1999; 94: 3976-85.
32. Lubke T, Marquardt T, von Figura K, Korner C. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J Biol Chem 1999; 274: 25986-9.
33. Etzioni A, Tonetti M. Fucose supplementation in leukocyte adhesion deficiency type II. Blood 2000; 95: 3641-3.
34. Hansske B, Thiel C, Lubke T, Hasilik M, Honing S, Peters V, et al. Deficiency of UDP-galactose: N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 2002; 109: 725-33.
35. Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 1984; 144: 245-7.
36. de Jong G, van Eijk HG. Microheterogeneity of human serum transferrin: a biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis 1988; 9: 589-98.
37. Seta N, Barnier A, Hochedez F, Besnard MA, Durand G. Diagnostic value of' Western blotting in carbohydrate-deficient glycoprotein syndrome. Clin Chim Acta 1996; 254: 131-40.
38. Barnier A, Dupre T, Cuer M, Vuillaumier-Barrot S, Durand G, Seta N. Leukocyte phosphomannomutase activity in diagnosis of congenital disorder of glycosylation Ia. Clin Chem 2002; 48: 934-6.